Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pariser

Showing results (101-110 of 193) with videos related to

Pageof 20
Sort By:
Clinical Pharmacology and Therapeutics|June 23, 2019
Secukinumab Treatment Does Not Alter the Pharmacokinetics of the Cytochrome P450 3A4 Substrate Midazolam in Patients With Moderate to Severe PsoriasisGerard Bruin, Anke Hasselberg, Irina Koroleva, et al.
Archives of Dermatology|December 1, 1996
Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled studyD M Pariser, R J Pariser, D Breneman, et al.
Journal of Drugs in Dermatology : JDD|March 9, 2016
Onychomycosis: Strategies to Minimize RecurrenceAditya K Gupta, Boni E Elewski, Ted Rosen, et al.
The Journal of Clinical and Aesthetic Dermatology|July 24, 2015
Bimatoprost 0.03% for the Treatment of Eyelash Hypotrichosis: A Pooled Safety Analysis of Six Randomized, Double-masked Clinical TrialsDavid Wirta, David M Pariser, Steven G Yoelin, et al.
Pediatric Dermatology|June 11, 2015
A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary HyperhidrosisDee Anna Glaser, David M Pariser, Adelaide A Hebert, et al.
Journal of the American Academy of Dermatology|October 22, 2011
Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasisDavid M Pariser, Craig L Leonardi, Kenneth Gordon, et al.
Journal of Drugs in Dermatology : JDD|May 12, 2016
Onychomycosis: Does Cure Equate to Treatment Success?Boni E Elewski, Aditya K Gupta, Ted Rosen, et al.
American Journal of Clinical Dermatology|September 5, 2020
The Effects of Once-Daily Tretinoin 0.05% Lotion on Quality of Life in Patients with Moderate-to-Severe Acne VulgarisStephen K Tyring, Leon Kircik, David M Pariser, et al.
Journal of the American Academy of Dermatology|February 13, 2003
Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trialDavid M Pariser, Nicholas J Lowe, Daniel M Stewart, et al.
Pediatric Dermatology|November 20, 2018
Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trialsAdelaide A Hebert, Dee Anna Glaser, Lawrence Green, et al.
Pageof 20

Showing results (101-110 of 193) with videos related to

Sort By:
Pageof 20
Clinical Pharmacology and Therapeutics|June 23, 2019
Secukinumab Treatment Does Not Alter the Pharmacokinetics of the Cytochrome P450 3A4 Substrate Midazolam in Patients With Moderate to Severe PsoriasisGerard Bruin, Anke Hasselberg, Irina Koroleva, et al.
Archives of Dermatology|December 1, 1996
Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled studyD M Pariser, R J Pariser, D Breneman, et al.
Journal of Drugs in Dermatology : JDD|March 9, 2016
Onychomycosis: Strategies to Minimize RecurrenceAditya K Gupta, Boni E Elewski, Ted Rosen, et al.
The Journal of Clinical and Aesthetic Dermatology|July 24, 2015
Bimatoprost 0.03% for the Treatment of Eyelash Hypotrichosis: A Pooled Safety Analysis of Six Randomized, Double-masked Clinical TrialsDavid Wirta, David M Pariser, Steven G Yoelin, et al.
Pediatric Dermatology|June 11, 2015
A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary HyperhidrosisDee Anna Glaser, David M Pariser, Adelaide A Hebert, et al.
Journal of the American Academy of Dermatology|October 22, 2011
Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasisDavid M Pariser, Craig L Leonardi, Kenneth Gordon, et al.
Journal of Drugs in Dermatology : JDD|May 12, 2016
Onychomycosis: Does Cure Equate to Treatment Success?Boni E Elewski, Aditya K Gupta, Ted Rosen, et al.
American Journal of Clinical Dermatology|September 5, 2020
The Effects of Once-Daily Tretinoin 0.05% Lotion on Quality of Life in Patients with Moderate-to-Severe Acne VulgarisStephen K Tyring, Leon Kircik, David M Pariser, et al.
Journal of the American Academy of Dermatology|February 13, 2003
Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trialDavid M Pariser, Nicholas J Lowe, Daniel M Stewart, et al.
Pediatric Dermatology|November 20, 2018
Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trialsAdelaide A Hebert, Dee Anna Glaser, Lawrence Green, et al.
Pageof 20